VEGFA and central nervous system cancer: In order to further improve the clinical value of inflammation-related prognosis models for the treatment of glioma, we analyzed the commonly used drugs in the clinical treatment of glioma, which include temozolomide, procarbazine, nitrosourea, vinblastine, podophyllotoxin, platinum, and molecular-targeted drugs targeting VEGF.